C Ardiet
Impact in
- Chemical Health and Safety top 5%
- Occupational Therapy top 5%
- Safe Handling of Antineoplastic Drugs
Papers in
- Oncology 19
- Cancer Treatment and Pharmacology 10
- Lung Cancer Research Studies 5
-
- Cancer therapeutics and mechanisms 11
- Co-authors
- Brigitte Tranchand (19 shared papers)Thierry Philip (4 shared papers)Paul Rebattu (6 shared papers)Pierre Biron (6 shared papers)Bertrand Favier (5 shared papers)Jean‐Paul Guastalla (3 shared papers)A Dumortier (5 shared papers)Gilles Freyer (5 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (6 papers)European Journal of Cancer (3 papers)Annals of Oncology (2 papers)Lung Cancer (2 papers)Investigational New Drugs (1 paper)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
C Ardiet
39 papers receiving 673 citations
Peers
Comparison fields: 5 of 83
- Chemical Health and Safety 20
- Occupational Therapy 71
- Oncology 324
- Hematology 96
- Microbiology 40
Countries citing papers authored by C Ardiet
This map shows the geographic impact of C Ardiet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Ardiet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Ardiet more than expected).
Fields of papers citing papers by C Ardiet
This network shows the impact of papers produced by C Ardiet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Ardiet. The network helps show where C Ardiet may publish in the future.
Co-authors
The 25 scholars most cited alongside C Ardiet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 98 | |
| 2 | 1992 | 75 | |
| 3 | 2003 | 50 | |
| 4 | 1986 | 36 | |
| 5 | 2000 | 35 | |
| 6 | 2001 | 35 | |
| 7 | Pharmacokinetics of alkylating agents. | 1993 | 34 |
| 8 | 1999 | 32 | |
| 9 | 1989 | 31 | |
| 10 | 1988 | 25 | |
| 11 | 1998 | 23 | |
| 12 | 2001 | 22 | |
| 13 | 1997 | 22 | |
| 14 | 2005 | 20 | |
| 15 | 2002 | 19 | |
| 16 | 1992 | 18 | |
| 17 | 1990 | 13 | |
| 18 | 1995 | 13 | |
| 19 | 2001 | 11 | |
| 20 | Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure. | 2003 | 11 |
About C Ardiet
C Ardiet is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Occupational Therapy and Hematology, having authored 39 papers that have together received 694 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (11 papers), Cancer Treatment and Pharmacology (10 papers), Safe Handling of Antineoplastic Drugs (5 papers), Lung Cancer Research Studies (5 papers), Multiple Myeloma Research and Treatments (4 papers), Chemotherapy-related skin toxicity (3 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Statistical Methods in Clinical Trials (3 papers). The work is most often cited by research in Chemical Health and Safety (20 citations), Occupational Therapy (71 citations), Oncology (324 citations), Hematology (96 citations) and Microbiology (40 citations). C Ardiet has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Brigitte Tranchand, Thierry Philip, Paul Rebattu, Pierre Biron, Bertrand Favier, Jean‐Paul Guastalla, A Dumortier, Gilles Freyer, G. Catimel and Droz Jp. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, European Journal of Cancer, Annals of Oncology, Lung Cancer and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.